Home Tools
Log in
Cart

DPP-4

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs, usually prescribed for people with type 2 diabetes.
Cat. No. Product name CAS No. Purity Chemical Structure
T68053 Denagliptin 483369-58-0 98%
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of typ...
T11248 Evogliptin tartrate 1222102-51-3 98%
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
T0178 Saxagliptin hydrate 945667-22-1 98%
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
T6192 Alogliptin 850649-61-5 98%
Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
T23358 Sitagliptin phosphate 654671-78-0 98%
Sitagliptin is a dipeptidyl peptidase-4 (DPP4) inhibitor.
T2316 Omarigliptin 1226781-44-7 98%
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
T0242L Sitagliptin phosphate monohydrate 654671-77-9 98%
Sitagliptin phosphate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
T15079 DBPR108 1186426-66-3 98%
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
T1581 Picolamine 3731-52-0 98%
Picolamine acts as a potential inhibitor of DPP-4.
T25340 Diprotin A 90614-48-5 98%
Diprotin A (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor.
T0191 Linagliptin 668270-12-0 98%
Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
T12710 Retagliptin Phosphate 1256756-88-3 98%
Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
T6237 Trelagliptin 865759-25-7 98%
Trelagliptin is a highly specific and long-acting DPP-4 inhibitor.
T11526 DPP-IV-IN-2 136259-18-2 98%
DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (DPIV) (IC50s: 0.1 and 0.95 μM).
TN1418 Azaleatin 529-51-1 98%
Azaleatin is a natural product Rhododendron simsii.
T1502 Vildagliptin 274901-16-5 98%
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiet...
T2296 Trelagliptin succinate 1029877-94-8 98%
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
T6999 Teneligliptin hydrobromide 906093-29-6 98%
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-...
T7133 Anagliptin 739366-20-2 98%
Anagliptin is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
T4042 Talabostat mesylate 150080-09-4 98%
Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation ...
Denagliptin
T68053
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of typ...
Evogliptin tartrate
T11248
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
Saxagliptin hydrate
T0178
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
Alogliptin
T6192
Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
Sitagliptin phosphate
T23358
Sitagliptin is a dipeptidyl peptidase-4 (DPP4) inhibitor.
Omarigliptin
T2316
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
Sitagliptin phosphate monohydrate
T0242L
Sitagliptin phosphate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
DBPR108
T15079
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
Picolamine
T1581
Picolamine acts as a potential inhibitor of DPP-4.
Diprotin A
T25340
Diprotin A (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor.
Linagliptin
T0191
Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
Retagliptin Phosphate
T12710
Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
Trelagliptin
T6237
Trelagliptin is a highly specific and long-acting DPP-4 inhibitor.
DPP-IV-IN-2
T11526
DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (DPIV) (IC50s: 0.1 and 0.95 μM).
Azaleatin
TN1418
Azaleatin is a natural product Rhododendron simsii.
Vildagliptin
T1502
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiet...
Trelagliptin succinate
T2296
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
Teneligliptin hydrobromide
T6999
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-...
Anagliptin
T7133
Anagliptin is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
Talabostat mesylate
T4042
Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation ...
1 2